Development of copper based drugs, radiopharmaceuticals and medical materials

BioMetals

Volumn 25, Issue 6, 2012, Pages 1089-1112

  Szymański, Paweł ^a   Fraczek, Tomasz ^a   Markowicz, Magdalena ^a   Mikiciuk Olasik, Elzbieta ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Copper; Drug development; Nanotechnology; Nuclear medicine

Indexed keywords

1,10 PHENANTROLINE; ACETYLSALICYLIC ACID; BIS VALPROINATO(1,10 PHENANTHROLINE); BIS(1,10 PHENANTHROLINE) L BIS(SALICYLATO); COPPER 60; COPPER 61; COPPER 62; COPPER 64; COPPER 67; COPPER DERIVATIVE; COPPER LEVO HISTIDINE; COPPER PALMITATE; DICLOFENAC; DISULFIRAM; GLUCONATE COPPER; IBUPROFEN; INDOMETACIN; MELOXICAM; NAPROXEN; PIROXICAM; RADIOISOTOPE; SALICYLIC ACID; UNCLASSIFIED DRUG;

ANTICONVULSANT ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BACTERIAL STRAIN; CLONIC SEIZURE; DERMATITIS; ELECTRIC SHOCK; FUNGAL STRAIN; HUMAN; LIVER METASTASIS; MAXIMAL ELECTROSHOCK; MENKES SYNDROME; NANOMEDICINE; NONHUMAN; NUCLEAR MEDICINE; POSITRON EMISSION TOMOGRAPHY; RHEUMATOID ARTHRITIS; SOLID TUMOR;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COPPER; HUMANS; NANOMEDICINE; NEOPLASMS; ORGANOMETALLIC COMPOUNDS; RADIOPHARMACEUTICALS;

EID: 84874108593     PISSN: 09660844     EISSN: 15728773     Source Type: Journal    
DOI: 10.1007/s10534-012-9578-y     Document Type: Article

References (207)

1. 4-methylthiosemicarbazone) using 2-deoxy-D-glucose. Cancer Res 63:5496-5504
2. Anderson CJ, Wadas TJ, Wong EH, Weisman GR (2008) Crossbridged macrocyclic chelators for stable complexation of copper radionuclides for PET imaging. Q J Nucl Med Mol Imaging 52:185-192
3. Azenha M, Vasconcelos MT, Cabral JPS (1995) Organic ligands reduce copper toxicity in Pseudomonas syringae. Environ Toxicol Chem 14:369-373
4. Balogh L, Nigavekar SS, Nair BM, Lesniak W, Zhang C, Sung LY, Kariapper MST, El-Jawahri A, Llanes M, Bolton B, Mamou F, Tan W, Hutson A, Minc L, Khan MK (2007) Significant effect of size on the in vivo biodistribution of gold composite nanodevices in mouse tumor models. Nanomedicine 4:281-296
5. Barceló-Oliver M, García-Raso Á, Terrón Á, Molins E, Prieto MJ, Moreno V, Martínez J, Lladó V, López I, Gutiérrez A, Escribá PV (2007) Synthesis and mass spectroscopy kinetics of a novel ternary copper(II) complex with cytotoxic activity against cancer cells. J Inorg Biochem 101:649-659
6. 64Cu]Cu-Bis(thiosemicarbazone) radiopharmaceutical binding to serum albumins. Nucl Med Biol 35:281-286
7. Bass LA, Wang M, Welch MJ, Anderson CJ (2000) In vivo transchelation of copper-64 from TETA-octreotide to superoxide dismutase in rat liver. Bioconjug Chem 11:527-532
8. Belicchi-Ferrari M, Bisceglie F, Casoli C, Durot S, Morgenstern-Badarau I, Pelosi G, Pilotti E, Pinelli S, Tarasconi P (2005) Copper(II) and cobalt(III) pyridoxal thiosemicarbazone complexes with nitroprusside as counterion: syntheses, electronic properties, and antileukemic activity. J Med Chem 48:1671-1675
9. Bertini I, Cavallaro G, McGreevy KS (2010) Cellular copper management-a draft user's guide. Coord Chem Rev 254:506-524
10. Bertrand V, Guessous F, Le Roy AL, Viossat B, Fessi H, El Abbouyi A, Giroud JP, Roch-Arveiller M (1999) Copperindomethacinate associated with zwitterionic phospholipids prevents enteropathy in rats: effect on inducible NO synthase. Dig Dis Sci 44:991-999
11. Bhattacharya J, Choudhuri U, Siwach O, Sen P, Dasgupta AK (2006) Interaction of hemoglobin and copper nanoparticles: implications in hemoglobinopathy. Nanomedicine 2:191-199
12. Bilgin MD, Elçin AE, Elçin YM (2005) Topical use of liposomal copper palmitate formulation blocks porphyrininduced photosensitivity in rats. J Photochem Photobiol B 80:107-114
13. 62Cu-ATSM PET in dogs with spontaneously occurring tumors. Phys Med Biol 53:217-232
14. Blower PJ, Lewis JS, Zweit J (1996) Copper Radionuclides and Radiopharmaceuticals in Nuclear Medicine. Nucl Med Biol 23:957-980
15. Bonardi ML, Groppi F, Birattari C, Gini L, Mainardi C, Ghioni A, Menapace E, Abbas K, Holzwarth U, Stroosnijder MF (2003) Thin-target excitation functions and optimization of simultaneous production of NCA copper-64 and gallium-66,67 by deuteron induced nuclear reactions on a natural zinc target. J Radioanal Nucl Chem 257:229-241
16. 64Cu(II)-Potential combination agents for the PET imaging of hypoxia. J Inorg Biochem 104:126-135
17. Boopathi M, Won M-S, Shim Y-B (2004) A sensor for acetaminophen in a blood medium using a Cu(II)-conducting polymer complex modified electrode. Anal Chim Acta 512:191-197
18. Borkow G, Gabbay J (2005) Copper as a biocidal tool. Curr Med Chem 12:2163-2175
19. Borkow G, Zatcoff RC, Gabbay J (2009) Reducing the risk of skin pathologies in diabetics by using copper impregnated socks. Med Hypotheses 73:883-886
20. Borkow G, Zhou SS, Page T, Gabbay J (2010) A novel antiinfluenza copper oxide containing respiratory face mask. PLoS ONE 5:e11295. doi:10.1371/journal. pone.0011295
21. Boswell CA, Sun X, Niu W, Weisman GR, Wong EH, Rheingold AL, Anderson CJ (2004) Comparative in Vivo Stability of Copper-64-Labeled Cross-Bridged and Conventional Tetraazamacrocyclic Complexes. J Med Chem 47:1465-1474
22. Brookhaven National Laboratory (2012) National Nuclear Data Center. http://www.nndc.bnl.gov. Accessed 5 March 2012
23. Burgman P, O'Donoghue JA, Lewis JS, Welch MJ, Humm JL, Ling CC (2005) Cell line-dependent differences in uptake and retention of the hypoxia-selective nuclear imaging agent Cu-ATSM. Nucl Med Biol 32:623-630
24. Cai H, Zhu N, Jiang Y, He P, Fang Y (2003) Cu@Au alloy nanoparticle as oligonucleotides labels for electrochemical stripping detection of DNA hybridization. Biosens Bioelectron 18:1311-1319
25. Cai S, Xia X, Xie C (2005) Corrosion behavior of copper/LDPE nanocomposites in simulated uterine solution. Biomaterials 26:2671-2676
26. 3. Cancer Res 66:9673-9681
27. Cai W, Gao T, Hong H, Sun J (2008) Applications of gold nanoparticles in cancer nanotechnology. Nanotechnol Sci Appl 1:17-32
28. Carrel F, Amstutz H, Novak-Hofer I, Schubiger PA (1997) Evaluation of radioiodinated and radiocopper labeled monovalent fragments of monoclonal antibody ch CE7 for targeting of neuroblastoma. Nucl Med Biol 24:539-546
29. Chakraborty A, Kumar P, Ghosh K, Roy P (2010) Evaluation of a Schiff base copper complex compound as potent anticancer molecule with multiple targets of action. Eur J Pharmacol 647:1-12
30. Chan RC, Lacy JL, Bhargava B, Collins SD, Cates P, Cottin Y, Kollum M, Yang N, Haynes NG, Martin CS, Nayak N, Vodovotz Y, Kim HS, Waksman R (2000) Anti-restenotic effect of copper-62 liquid-filled balloon in porcine coronary arteries: novel use of a short half-life positron emitter. Int J Radiat Oncol Phys 48:583-592
31. Chao KSC, Bosch WR, Mutic S, Lewis JS, Dehdashti F, Mintun MA, Dempsey JF, Perez CA, Purdy JA, Welch MJ (2001) A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided Intensity-Modulated Radiation Therapy. Int J Radiat Oncol Biol Phys 49:1171-1182
32. 64Cu-Labeled Dimeric RGD Peptides. Mol Imag Biol 6:350-359
33. Chen D, Cui QC, Yang H, Dou QP (2006) Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity. Cancer Res 66:10425-10433
34. Chen K, Li Z-B, Wang H, Cai W, Chen X (2008) Dual-modality optical and positron emission tomography imaging of vascular endothelial growth factor receptor on tumor vasculature using quantum dots. Eur J Nucl Med Mol Imaging 35:2235-2244
35. Chen J, Glaus C, Laforest R, Zhang Q, Yang M, Gidding M, Welch MJ, Xia Y (2010) Gold Nanocages as Photothermal Transducers for Cancer Treatment. Small 6:811-817
36. 64Cu-Labeled Alpha-Melanocyte-Stimulating Hormone Analog for Micro PET Imaging of Melanocortin 1 Receptor Expression. Bioconjug Chem 18:765-772
37. Choi WI, Kim JY, Kang C, Byeon CC, Kim YH, Tae G (2011) Tumor Regression In Vivo by Photothermal Therapy Based on Gold-Nanorod-Loaded, Functional Nanocarriers. ACS Nano 5:1995-2003
38. Cini R, Giorgi G, Cinquantini A, Rossi C, Sabat M (1990) Metal Complexes of the Antiinflammatory Drug Piroxicam. Inorg Chem 29:5197-5200
39. Cini R, Tamasi G, Defazio S, Hursthouse MB (2007) Unusual coordinating behavior by three non-steroidal anti-inflammatory drugs from the oxicam family towards copper(II). Synthesis, X-ray structure for copper(II)-isoxicam,- meloxicam and-cinnoxicam-derivative complexes, and cytotoxic activity for a copper(II)-piroxicam complex. J Inorg Biochem 101:1140-1152
40. Clinical Trials.gov (2012) http://clinicaltrials.gov. Accessed 4 March 2012
41. 61Cu using natural cobalt target and its separation using ascorbic acid and common anion exchange resin. Appl Radiat Isot 70:365-368
42. Dearling JLJ, Packard AB (2010) Some thoughts on the mechanism of cellular trapping of Cu(II)-ATSM. Nucl Med Biol 37:237-243
43. 60Cu-ATSM. Eur J Nucl Med Mol Imaging 30:844-850
44. 4-Methylthiosemicarbazone). J Nucl Med 49:201-205
45. Delaloye AB, Delaloye B, Buchegger F, Vogel CA, Gillet M, Mach JP, Smith A, Schubiger PA (1997) Comparison of copper-67-and iodine-125-labeled anti-CEA monoclonal antibody biodistribution in patients with colorectal tumors. J Nucl Med 38:847-853
46. 67Cu-21TBAT-Lym1-Pharmacokinetics, Radiation Dosimetry, Toxicity and Tumor Regression in Patients with Lymphoma. J Nucl Med 40:302-310
47. DeNardo GL, DeNardo SJ, O'Donnell RT, Kroger LA, Kukis DL, Meares CF, Goldstein DS, Shen S (2000) Are Radiometal-Labeled Antibodies Better Than Iodine-131-Labeled Antibodies: comparative Pharmacokinetics and Dosimetry of Copper-67-, Iodine-131-, and Yttrium-90-Labeled Lym-1 Antibody in Patients with Non-Hodgkin's Lymphoma. Clin Lymphoma 1:118-126
48. Derfus AM, Chan WCW, Bhatia SN (2004) Probing the cytotoxicity of semiconductor quantum dots. Nano Lett 4:11-18
49. 60Cu-ATSM as a predictor of response and survival in patients undergoing Neoadjuvant chemoradiotherapy for rectal carcinoma: a pilot study. Dis Colon Rectum 51: 1641-1648
50. Dijkgraaf I, Rijnders AY, Soede A, Dechesne AC, van Esse GW, Brouwer AJ, Corstens FH, Boerman OC, Rijkers DT, Liskamp RM (2007) Synthesis of DOTA-conjugated multivalent cyclic-RGD peptide dendrimers via 1,3-dipolar cycloaddition and their biological evaluation: implications for tumor targeting and tumor imaging purposes. Org Biomol Chem 5:935-944
51. Ding X, Xie H, Kang YJ (2011) The significance of copper chelators in clinical and experimental application. J Nutr Biochem 22:301-310
52. Dong YP, Pei LZ, Chu XF, Zhang WB, Zhang QF (2010) Electrochemical behavior of cysteine at a Cu GeO3 nanowires modified glassy carbon electrode. Electrochim Acta 55:5135-5141
53. Dutta S, Padhye S, Mckee V (2004) Structural characterization and SOD activity of copper-oxaprozinate. Inorg Chem Commun 7:1071-1074
54. 64Cu-Labeled Chelator-Somatostatin Conjugates in an SSTr2-Transfected Human Tumor Cell Line. J Nucl Med 48:1390-1396
55. 62Cu generator. Appl Radiat Isot 69:1176-1180
56. Emerit J, Pelletier S, Likforman J, Pasquier C, Thuillier A (1991) Phase II trial of copper zinc superoxide dismutase (Cu Zn SOD) in the treatment of Crohn's disease. Free Radic Res Commun 13:563-569
57. Engelhardt EL, Schneider RF, Seeholzer SH, Stobbe CC, Chapman JD (2002) The Synthesis and Radiolabeling of 2-Nitroimidazole Derivatives of Cyclam and Their Preclinical Evaluation as Positive Markers of Tumor Hypoxia. J Nucl Med 43:837-850
58. Farley TM, Rosenberg MJ, Rowe PJ, Chen JH, Meirik O (1992) Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet 339:785-788
59. Ferrer EG, Baeza N, Naso LG, Castellano EE, Piro OE, Williams PAM (2010) Superoxidedismutase-mimetic copper(II) complexes containing saccharinate and 4-aminopyridine/4-cyanopyridine. J Trace Elem Med Biol 24:20-26
60. Firme CP III, Bandaru PR (2010) Toxicity issues in the application of carbon nanotubes to biological systems. Nanomedicine 6:245-256
61. Franco L, Doria D (1997) Prostaglandins and Nitric Oxide in Copper-Complex Mediated Protection Against Ethanol-Induced Gastric Damage. Pharmacol Res 36:395-399
62. Fujita K, Muraki T, Hattori H, Sakakura T (2006) Diels-Alder reaction using a dendritic copper(II) triflate-catalyst: a positive dendritic effect on the chemical yield. Tetrahedron Lett 47:4831-4834
63. 62Cu generator based on a cation exchanger and its fully remote-controlled preparation for clinical use. Nucl Med Biol 33:821-827
64. Galibert M, Jin ZH, Furukawa T, Fukumura T, Saga T, Fujibayashi Y, Dumy P, Boturyn D (2010) RGD-cyclam conjugate: synthesis and potential application for positron emission tomography. Bioorg Med Chem Lett 20: 5422-5425
65. Gao X, Yang L, Petros JA, Marshall FF, Simons JW, Nie S (2005) In vivo molecular and cellular imaging with quantum dots. Curr Opin Biotechnol 16:63-72
66. Garcia-González A, Lotz M, Ochoa JL (2009) Anti-inflammatory activity of superoxide dismutase obtained from Debaryomyces hansenii on type II collagen induced arthritis in rats. Rev Invest Clin 61:212-220
67. Ghosh K, Kumar P, Tyagi N, Singh UP, Aggarwal V, Baratto MC (2010) Synthesis and reactivity studies on new copper( II) complexes: DNA binding, generation of phenoxyl radical, SOD and nuclease activities. Eur J Med Chem 45:3770-3779
68. Gölcü A, Dolaz M, Daǧci EK (2005) Synthesis of Binuclear Copper (II) Complex of the Antihypertensive Drug Pindolol. KSU J Sci Eng 8:4-9
69. Goldenberg DM, Sharkey RM (2006) Advances in cancer therapy with radiolabeled monoclonal antibodies. Q J Nucl Med Mol Imaging 50:248-264
70. González-Baró AC, Pis-Diez R, Franca CA, Torre MH, Parajón-Costa BS (2010) Physicochemical characterization of Cu(II) complexes with SOD-like activity, theoretical studies and biological assays. Polyhedron 29:959-968
71. Grace M, Chand N, Bajpai SK (2009) Copper Alginate-Cotton Cellulose (CACC) Fibers with Excellent Antibacterial Properties. J Eng Fiber Fabr 4:24-35
72. Green MA, Mathias CJ, Willis LR, Handa RK, Lacy JL, Miller MA, Hutchins GD (2007) Assessment of Cu-ETS as a PET radiopharmaceutical for evaluation of regional renal perfusion. Nucl Med Biol 34:247-255
73. Gunawan C, Teoh WY, Marquis CP, Amal R (2011) Cytotoxic Origin of Copper(II) Oxide Nanoparticles: comparative Studies with Micron-Sized Particles, Leachate, and Metal Salts. ACS Nano 5:7214-7225
74. Guo AJ, Xu XS, Hu YH, Wang MZ, Tan X (2010) Effects of ternary complexes of copper with salicylaldehyde-amino acid Schiff base coordination compounds on the proliferation of BGC823 cells. Chin J Cancer 29:277-282
75. Han Y, Shen T, Jiang W, Xia Q, Liu C (2007) DNA cleavage mediated by copper superoxide dismutase via two pathways. J Inorg Biochem 101:214-224
76. 61Cu-DOTA-HAS as a blood pool agent. Appl Radiat Isot 67:511-515
77. Heli H, Jabbari A, Zarghan M, Moosavi-Movahedi AA (2009) Copper nanoparticles-carbon microparticles nanocomposite for electrooxidation and sensitive detection of sotalol. Sens Actuators, B 140:245-251
78. Hoffman TJ, Smith CJ (2009) True radiotracers: Cu-64 targeting vectors based upon bombesin peptide. Nucl Med Biol 36:579-585
79. Holschneider DP, Maarek JMI (2004) Mapping brain function in freely moving subjects. Neurosci Biobeh Rev 28: 449-461
80. Hopkins RG, Failla ML (1999) Transcriptional regulation of interleukin-2 gene expression is impaired by copper deficiency in Jurkat human T lymphocytes. J Nutr 129: 596-601
81. Hostýnek JJ, Dreher F, Maibach HI (2006) Human stratum corneum penetration by copper: in vivo study after occlusive and semi-occlusive application of the metal as powder. Food Chem Toxicol 44:1539-1543
82. Huang ZL, Failla ML (2000) Copper deficiency suppresses effector activities of differentiated U937 cells. J Nutr 130:1536-1542
83. Hughes ODM, Bishop MC, Perkins AC, Wastie ML, Denton G, Price MR, Frier M, Denley H, Rutherford R, Schubiger PA (2000) Targeting Superficial Bladder Cancer by the Intravesical Administration of Copper-67-Labeled Anti-MUC1 Mucin Monoclonal Antibody C595. J Clin Oncol 18: 363-370
84. II(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson's disease. JEM 209:837-854
85. Ibrahim MM, Ramadan AMM, Mersal GAM, El-Shazly SA (2011) Synthesis, superoxide dismutase, nuclease, and anticancer activities of copper(II) complexes incorporating bis(2-picolyl)amine with different counter anions. J Mol Struct 998:1-10
86. 62Cu-ATSM PET for evaluation of brain ischaemia and misery perfusion in patients with cerebrovascular disease. Eur J Nucl Med Mol Imaging 38:1075-1082
87. Jackson GE, Mkhonta-Gama L, Voye A, Kelly M(2000) Design of copper-based anti-inflammatory drugs. J Inorg Biochem 79:147-152
88. 61Cu]-2-acetylpyridine thiosemicarbazone complex as a possible PET tracer for malignancies. Appl Radiat Isot 64:337-341
89. 64Cu-Labeled Magnetic Nanoparticles for Multimodal Imaging. Bioconjug Chem 19:1496-1504
90. Jiang LC, Zhang WD (2010) A highly sensitive nonenzymatic glucose sensor based on CuO nanoparticles-modified carbon nanotube electrode. Biosens Bioelectron 25:1402-1407
91. Jin L, Yang S-P, Tian Q-W, Wu H-X, Cai Y-J (2008) Preparation and characterization of copper metal nanoparticles using dendrimers as protectively colloids. Mater Chem Phys 112:977-983
92. 4. Nucl Med Biol 38:529-540
93. Kao CL, Tang YH, Lin YC, Chiu LT, Chen HT, Hsu SC, Hsieh KC, Lu CY, Chen YL (2011) Copper complex of a pyridine-modified poly(amidoamine) dendrimer as a chemical nuclease: synthetic and catalytic study. Nanomedicine 7:273-276
94. 68Zn target. J Radioanal Nucl Chem 277:467-470
95. Knogler K, Grünberg J, Zimmermann K, Cohrs S, Honer M, Ametamey S, Altevogt P, Fogel M, Schubiger PA, Novak-Hofer I (2007) Copper-67 Radioimmunotherapy and Growth Inhibition by Anti-L1-Cell Adhesion Molecule Monoclonal Antibodies in a Therapy Model of Ovarian Cancer Metastasis. Clin Cancer Res 13:603-611
96. Kofoed J, Reymond JL (2005) Dendrimers as artificial enzymes. Curr Opin Chem Biol 9:656-664
97. Kovala-Demertzi D, Galani A, Demertzis MA, Skoulika S, Kotoglou C (2004) Binuclear copper(II) complexes of tolfenamic: synthesis, crystal structure, spectroscopy and superoxide dismutase activity. J Inorg Biochem 98: 358-364
98. Kumar RS, Arunachalam S (2009) DNA binding and antimicrobial studies of polymer-copper(II) complexes containing 1,10-phenanthroline and L-phenylalanine ligands. Eur J Med Chem 44:1878-1883
99. 60/61/62/64Cu-ATSM: a hypoxia imaging agent for PET. Eur J Nucl Med Mol Imaging 32:764-770
100. 64Cu-NO2A-(X)-BBN(7-14) NH2], in a prostate tumor xenografted mouse model. Nucl Med Biol 37:751-761
101. 64Cu radioisotope production. Appl Radiat Isot 67:1324-1331
102. Lee H-Y, Li Z, Chen K, Hsu AR, Xu C, Xie J, Sun S, Chen X (2008) PET/MRI Dual-Modality Tumor Imaging Using Arginine-Glycine-Aspartic (RGD)-Conjugated Radiolabeled Iron Oxide Nanoparticles. J Nucl Med 49:1371-1379
103. Lemoine P, Viossat B, Morgant G, Greenaway FT, Tomas A, Dung NH, Sorenson JRJ (2002) Synthesis, crystal structure, EPR properties, and anticonvulsant activities of binuclear and mononuclear 1,10-phenanthroline and salicylate ternary copper(II) complexes. J Inorg Biochem 89:18-28
104. 64Cu-DOTA-Cetuximab, a PET-Imaging Agent for Epidermal Growth-Factor Receptor-Positive Tumors. Cancer Biother Radiopharm 23:158-171
105. Li Y, Lu W, Huang Q, Huang M, Li C, Chen W (2010) Copper sulfide nanoparticles for photothermal ablation of tumor cells. Nanomedicine 5:1161-1171
106. Li N, Kang G, Gui L, Zhao M, Wang W, Zhang J, Yue YF, Peng S (2011) Novel Cu(II)-RGD-octapeptides: synthesis, coordination mode, in vitro anti-platelet aggregation/in vivo anti-thrombotic evaluation and correlation of sequence with nano-structure. Nanomedicine 7:403-409
107. Liu X, Laforest R (2009) Quantitative small animal PET imaging with nonconventional nuclides. Nucl Med Biol 36:551-559
108. Liu G, Wang J, Kim J, Jan MR, Collins GE (2004) Electrochemical coding for multiplexed immunoassays of proteins. Anal Chem 76:7126-7130
109. Liu Z, Cai W, He L, Nakayama N, Chen K, Sun X, Chen X, Dai H (2007) In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. Nat Nanotechnol 2:47-52
110. Liu Z, Davis C, Cai W, He L, Chen X, Dai H (2008) Circulation and long-term fate of functionalized, biocompatible singlewalled carbon nanotubes in mice probed by Raman spectroscopy. Proc Natl Acad Sci USA 105:1410-1415
111. Ma D, Lu F, Overstreet T, Milenic DE, Brechbiel MW (2002) Novel chelating agents for potential clinical applications of copper. Nucl Med Biol 29:91-105
112. Maiti M, Sen K, Sen S, Lahiri S (2011) Studies on stabilities of some human chorionic gonadotropin complexes with bemitting radionuclides. Appl Radiat Isot 69:316-319
113. Male KB, Hrapovic S, Liu Y, Wang D, Luong JHT (2004) Electrochemical detection of carbohydrates using copper nanoparticles and carbon nanotubes. Anal Chim Acta 516:35-41
114. Mathias CJ, Bergmann SR, Green MA (1995) Species-dependent binding of copper(II) bis(thiosemicarbazone) radiopharmaceuticals to serum albumin. J Nucl Med 36: 1451-1455
115. McCarthy DW, Bass LA, Cutler PD, Shefer RE, Klinkowstein RE, Herrero P, Lewis JS, Cutler CS, Anderson CJ, Welch MJ (1999) High purity production and potential applications of copper-60 and copper-61. Nucl Med Biol 26: 351-358
116. 64Cu-labeled Bis(selenosemicarbazone) and Bis(thiosemicarbazone) complexes as hypoxia imaging agents. Nucl Med Biol 32: 147-156
117. 68Zn cycle. Appl Radiat Isot 70:423-429
118. 64Cu labeled affibody protein. Bioconjug Chem 21:947-954
119. 62Cu-ATSM PET/CT as a predictor of response in head and neck cancer: a pilot study. Ann Nucl Med 25:339-345
120. 67Cu-Antibody Conjugate to Ceruloplasmin in Lymphoma Patients. Nucl Med Biol 26:841-845
121. Mookerjee A, Mookerjee Basu J, Dutta P, Majumder S, Bhattacharyya S, Biswas J, Pal S, Mukherjee P, Raha S, Baral RN, Das T, Efferth T, Sa G, Roy S, Choudhuri SK (2006) Overcoming drug-resistant cancer by a newly developed copper chelate through host-protective cytokine-mediated apoptosis. Clin Cancer Res 12:4339-4349
122. Mora N, Cano E, Mora EM, Bastidas JM (2002) Influence of pH and oxygen on copper corrosion in simulated uterine fluid. Biomaterials 23:667-671
123. Nan L, Yang W, Liu Y, Xu H, Li Y, Lü M, Yang K (2008) Antibacterial Mechanism of Copper-bearing Antibacterial Stainless Steel against E. Coli. J Mater Sci Technol 24:197-201
124. Novak-Hofer I, Schubiger PA (2002) Copper-67 as a therapeutic nuclide for radioimmunotherapy. Eur J Nucl Med 29: 821-830
125. O'Donoghue JA, Bardiès M, Wheldon TE (1995) Relationship between Tumor Size and Curability for Uniformly Targeted Therapy with Beta-Emitting Radionuclides. J Nucl Med 36:1902-1909
126. O'Reilly RK, Hawker CJ, Wooley KL (2006) Cross-linked block copolymer micelles: functional nanostructures of great potential and versatility. Chem Soc Rev 35: 1068-1083
127. 64Cu using a 12 Me V cyclotron. Nucl Med Biol 30:535-539
128. 2 donor ligands-Potential anti-inflammatory drugs. Inorg Chim Acta 362:125-135
129. Odisitse S, Jackson GE, Govender T, Kruger HG, Singh A (2007) Chemical speciation of copper(II) diaminediamide derivative of pentacycloundecane-a potential anti-inflammatory agent. Dalton Trans 11:1140-1149
130. Ohsumi Y, Kitamoto K, Anraku Y (1988) Changes induced in the permeability barrier of the yeast plasma membrane by cupric ion. J Bacteriol 170:2676-2682
131. 64Culabeled monocationic Copper(II) complex. Nucl Med Biol 29:289-294
132. Pontiki E, Hadjipavlou-Litina D, Chaviara AT, Bolos CA (2006) Evaluation of anti-inflammatory and antioxidant activities of mixed-ligand Cu(II) complexes of dien and its Schiff dibases with heterocyclic aldehydes and 2-amino-2-thiazoline. Bioorg Med Chem Lett 16:2234-2237
133. 2]: a site-directed radiopharmaceutical for positron-emission tomography imaging of T-47D human breast cancer tumors. Nucl Med Biol 36:171-181
134. Puig S, Thiele DJ (2002) Molecular mechanisms of copper uptake and distribution. Curr Opin Chem Biol 6:171-180
135. Raffi M, Mehrwan S, Bhatti TM, Akhter JI, Hameed A, Yawar W, ul Hasan MM (2010) Investigations into the antibacterial behavior of copper nanoparticles against Escherichia coli. Ann Microbiol 60:75-80
136. 2+ complexes of first and second generation dendrimers. Spectrochim Acta A 72:772-782
137. Reilly RM (2006) Radioimmunotherapy of Solid Tumors: the Promise of Pretargeting Strategies Using Bispecific Antibodies and Radiolabeled Haptens. J Nucl Med 47:196-199
138. Reilly RM (ed) (2010) Monoclonal antibody and peptide-targeted radiotherapy of cancer. John Wiley and Sons, Hoboken
139. Ren X, Cui G, Zhao M, Wang C, Peng S (2008) Coordination of thrombolytic Pro-Ala-Lys peptides with Cu (II): leading to nanoscale self-assembly, increase of thrombolytic activity and additional vasodilation. J Phys Chem B 112:8174-8180
140. 64Cu-labeled folate-conjugated shell crosslinked nanoparticles for tumor imaging and radiotherapy: synthesis, radiolabeling, and biologic evaluation. J Nucl Med 46:1210-1218
141. natZn at a medical cyclotron. Appl Radiat Isot 64:1563-1573
142. Roy S, Banerjee R, Sarkar M (2006) Direct binding of Cu(II)-complexes of oxicam NSAIDs with DNA backbone. J Inorg Biochem 100:1320-1331
143. Ruangma A, Bai B, Lewis JS, Sun X, Welch MJ, Leahy R, Laforest R (2006) Three-dimensional maximum a posteriori (MAP) imaging with radiopharmaceuticals labeled with three Cu radionuclides. Nucl Med Biol 33:217-226
144. Rzigalinski BA, Strobl J (2009) Cadmium-containing nanoparticles: perspectives on pharmacology and toxicology of quantum dots. Toxicol Appl Pharm 238:280-288
145. 4+ on the synthesis and catabolism of prostaglandins in rabbit gastric antral mucosa. Prostagland Leukot Essent Fatty Acids 54:193-197
146. 2+ as modulators of formation of the two products. Prostagland Leukot Essent Fatty Acids 61:105-112
147. 5 ligands. Bioorg Med Chem 16:4262-4271
148. Sampath L, Kwon S, Hall MA, Price RE, Sevick-Muraca EM (2010) Detection of cancer metastases with a dual-labeled near-infrared/positron emission tomography imaging agent. Transl Oncol 3:307-317
149. Sang RL, Yang P (2005) Efficient DNA cleavage by copper(II) complex derived from 1, 1′-dimethyl-2, 2′-biimidazole ligand. Chinese Chem Lett 16:1397-1400
150. Seng HL, Tan KW, Maah MJ, Tan WT, Hamada H, Chikira M, Ng CH (2009) Copper(II) complexes of methylated glycine derivatives: effect of methyl substituent on their DNA binding and nucleolytic property. Polyhedron 28:2219-2227
151. Shakir M, Azim Y, Chishti HTN, Parveen S (2006) Synthesis, characterization of complexes of Co(II), Ni(II), Cu(II) and Zn(II) with 12-membered Schiff base tetraazamacrocyclic ligand and the study of their antimicrobial and reducing power. Spectrochim Acta A 65:490-496
152. Sheikh FA, Kanjwal MA, Saran S, Chung WJ, Kim H (2011) Polyurethane nanofibers containing copper nanoparticles as future materials. Appl Surf Sci 257:3020-3026
153. Singh BK, Bhojak N, Mishra P, Garg BS (2008) Copper(II) complexes with bioactive carboxyamide: synthesis, characterization and biological activity. Spectrochim Acta A 70:758-765
154. Singh AP, Kaushik NK, Verma AK, Hundal G, Gupta R (2009) Synthesis, structure and biological activity of copper(II) complexes of 4-(2-pyridylmethyl)-1,7-dimethyl-1,4,7-triazonane-2,6-dione and 4-(2-pyridylethyl)-1,7-dimethyl-1,4,7-triazonane-2,6-dione. Eur J Med Chem 44: 1607-1614
155. Sorenson JRJ (1976) Copper chelates as possible active forms of the antiarthritic agents. J Med Chem 19:135-148
156. Sorenson JRJ (1982) In: Sigel H (ed) Inorganic drugs in deficiency and disease. Metalions in biological systems, vol 14. Marcel Dekker, New York
157. Sorenson JRJ (ed) (1987) Biology of copper complexes. Humana Press, Clifton
158. Sorenson JRJ (1989) 6 copper complexes offer a physiological approach to treatment of chronic diseases. Prog Med Chem 26:437-568
159. 3-octreotate using a crossbridged macrocyclic chelator. Clin Cancer Res 10: 8674-8682
160. Sprague JE, Li WP, Liang K, Achilefu S, Anderson CJ (2006) In vitro and in vivo investigation of matrix metalloproteinase expression in metastatic tumor models. Nucl Med Biol 33:227-237
161. Sreedaran S, Bharathi KS, Rahiman AK, Jagadish L, Kaviyarasan V, Narayanan V (2008) Novel unsymmetrical macrocyclic dicompartmental binuclear copper(II) complexes bearing 4-and 6-coordination sites: electrochemical, magnetic, catalytic and antimicrobial studies. Polyhedron 27:2931-2938
162. Sreedhara A, Freed JD, Cowan JA (2000) Efficient inorganic deoxyribonucleases greater than 50-million-fold rate enhancement in enzyme-like DNA cleavage. J Am Chem Soc 122:8814-8824
163. Studer AM, Limbach LK, Van Duc L, Krumeich F, Athanassiou EK, Gerber LC, Moch H, Stark WJ (2010) Nanoparticle cytotoxicity depends on intracellular solubility: comparison of stabilized copper metal and degradable copper oxide nanoparticles. Toxicol Lett 197:169-174
164. Suksrichavalit T, Prachayasittikul S, Piacham T, Isarankura-Na-Ayudhya C, Nantasenamat C, Prachayasittikul V (2008) Copper complexes of nicotinic-aromatic carboxylic acids as superoxide dismutase mimetics. Molecules 13:3040-3056
165. Suksrichavalit T, Prachayasittikul S, Nantasenamat C, Isarankura-Na-Ayudhya C, Prachayasittikul V (2009) Copper complexes of pyridine derivatives with superoxide scavenging and antimicrobial activities. Eur J Med Chem 44:3259-3265
166. Sylla-Iyarreta Veitía M, Dumas F, Morgant G, Sorenson JRJ, Frapart Y, Tomas A (2009) Synthesis, structural analysis and anticonvulsant activity of a ternary Cu(II) mononuclear complex containing 1,10-phenanthroline and the leading antiepileptic drug valproic acid. Biochimie 91: 1286-1293
167. 64Cu]Cu-ATSM for PET studies. Radiochim Acta 93:239-244
168. Taggar AS, Alnajim J, Anantha M, Thomas A, Webb M, Ramsay E, Bally MB (2006) Copper-topotecan complexation mediates drug accumulation into liposomes. J Control Release 114:78-88
169. Takahashi N, Fujibayashi Y, Yonekura Y, Welch MJ, Waki A, Tsuchida T, Sadato N, Sugimoto K, Nakano A, Lee JD, Itoh H (2001) Copper-62 ATSM as a hypoxic tissue tracer in myocardial ischemia. Ann Nucl Med 15:293-296
170. Taraszka JA, Li J, Clemmer DE (2000) Metal-mediated peptide ion conformations in the gas phase. J Phys Chem B 104:4545-4551
171. 90Yttrium-labeled monoclonal antibody CC49: A phase I trial. Clin Cancer Res 6:3095-3102
172. 99mTc-VIP analog. J Nucl Med 45:1381-1389
173. Thurber GM, Schmidt MM, Wittrup KD (2008) Antibody tumor penetration: transport opposed by systemic and antigenmediated clearance. Adv Drug Deliv Rev 60:1421-1434
174. Tian ZQ, Bartlett PA (1996) Metal coordination as a method for templating peptide conformation. J Am Chem Soc 118:943-949
175. Tian X, Zhang Z, Wang S, Diao Y, Zhao Z, Lv D (2009) Copper-taurine (CT): a potential organic compound to facilitate infected wound healing. Med Hypotheses 73:1048-1050
176. Timonen H (1976) Copper release from copper-T intrauterine devices. Contraception 14:25-38
177. Toyota E, Sekizaki H, Takahashi Y, Itoh K, Tanizawa K (2005) Amidino-containing Schiff base copper(II) and iron(III) chelates as a thrombin inhibitor. Chem Pharm Bull 53:22-26
178. Tuorkey MJF-A, Abdul-Aziz KK (2009) A pioneer study on the anti-ulcer activities of copper nicotinate complex [Cu Cl (HNA)2] in experimental gastric ulcer induced by aspirinpyloris ligation model (Shay model). Biomed Pharmacother 63:194-201
179. Vegt E, de Jong M, Wetzels JFM, Masereeuw R, Melis M, Oyen WJG, Gotthardt M, Boerman OC (2010) Renal toxicity of radiolabeled peptides and antibody fragments: mechanisms, impact on radionuclide therapy, and strategies for prevention. J Nucl Med 51:1049-1058
180. Wadas TJ, Wong EH, Weisman GR, Anderson CJ (2010) Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease. Chem Rev 110:2858-2902
181. Wan YZ, Xiong GY, Liang H, Raman S, He F, Huang Y (2007) Modification of medical metals by ion implantation of copper. Appl Surf Sci 253:9426-9429
182. Webster TJ (ed) (2011) Nanotechnology enabled in situ sensors for monitoring health. Springer, New York
183. Weder JE, Hambley TW, Kennedy BJ, Lay PA, MacLachlan D, Bramley R, Delfs CD, Murray KS, Moubaraki B, Warwick B, Biffin JR, Regtop HL (1999) Anti-inflammatory dinuclear copper(II) complexes with indomethacin. Synthesis, magnetism and epr spectroscopy. Crystal structure of the N,N-dimethylformamide adduct. Inorg Chem 38:1736-1744
184. Weder JE, Dillon CT, Hambley TW, Kennedy BJ, Lay PA, Biffin JR, Regtop HL, Davies NM (2002) Copper complexes of non-steroidal anti-inflammatory drugs: an opportunity yet to be realized. Coord Chem Rev 232:95-126
185. 64Culabeled rhenium-cyclized a-MSH peptide analog using a cross-bridged cyclam chelator. J Nucl Med 48:64-72
186. 64Cu-Labeled CB-TE2A and diamsarconjugated RGD peptide analogs for targeting angiogenesis: comparison of their biological activity. Nucl Med Biol 36:277-285
187. Williams HA, Robinson S, Julyan P, Zweit J, Hastings D (2005) A comparison of PET imaging characteristics of various copper radioisotopes. Eur J Nucl Med Mol Imaging 32:1473-1480
188. 62Cu generator. AJR 190:427-432
189. Wu Y, Han G, Gong Y, Zhang Y, Xia Y, Yue C, Wu D (2011) Antibacterial property and mechanism of copper alginate fiber. Adv Mater Res 152-153:1351-1355
190. Xu Q, Zhao Y, Xu JZ, Zhu JJ (2006) Preparation of functionalized copper nanoparticles and fabrication of a glucose sensor. Sens Actuators, B 114:379-386
191. Yang BY, Chen XM, Deng GJ, Zhang YL, Fan QH (2003) Chiral dendritic bis(oxazoline) copper(II) complexes as Lewis acid catalysts for enantioselective aldol reactions in aqueous media. Tetrahedron Lett 44:3535-3538
192. 64Cu-labeled bombesin analogs in a mouse model of human prostate adenocarcinoma. Nucl Med Biol 33:371-380
193. Yang M, Cui G, Zhao M, Wang C, Wang L, Liu H, Peng S (2008) The effect of complexation of Cu(II) with P6A peptide and its analogs on their thrombolytic activities. Int J Pharm 362:81-87
194. Yong KT, Roy I, Hu R, Ding H, Cai H, Zhu J, Zhang X, Bergey EJ, Prasad PN (2010) Synthesis of ternary Cu InS2/ZnS quantum dot bioconjugates and their applications for targeted cancer bioimaging. Integr Biol 2:121-129
195. 64Cu-labeled anti-C-kit 12A8 Fab tomeasure protooncogene C-kit expression. Nucl Med Biol 38:331-337
196. + highly tumorigenic cells andmetastatic ability ofmouse colon carcinoma. Nucl Med Biol 38:151-157
197. Zatcoff RC, Smith MS, Borkow G (2008) Treatment of tinea pedis with socks containing copper-oxide impregnated fibers. The Foot 18:136-141
198. Zen J-M, Hsu C-T, Kumar AS, Lyuu H-J, Lin K-Y (2004) Amino acid analysis using disposable copper nanoparticle plated electrodes. Analyst 129:841-845
199. Zhang Y, Wang JZ, Wu YJ, Li WG (2002) Anti-inflammatory effect of recombinant human superoxide dismutase in rats and mice and its mechanism. Acta Pharmacol Sin 23:439-444
200. Zhang K, Aruva MR, Shanthly N, Cardi CA, Patel CA, Rattan S, Cesarone G, Wickstrom E, Thakur ML (2007a) Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating peptide (PACAP) receptor specific peptide analogues for PET imaging of breast cancer: in vitro/in vivo evaluation. Regul Peptides 144:91-100
201. Zhang W, Zhang Y, Ji J, Yan Q, Huang A, Chu PK (2007b) Antimicrobial polyethylene with controlled copper release. J Biomed Mater Res A 83:838-844
202. Zhang Y, Kundu B, Fairchild KD, Locke L, Berr SS, Linden J, Pan D (2007c) Synthesis of novel neutrophil-specific imaging agents for positron emission tomography (PET) imaging. Bioorg Med Chem Lett 17:6876-6878
203. Zhang H, Yee D, Wang C (2008) Quantum dots for cancer diagnosis and therapy: biological and clinical perspectives. Nanomedicine 3:83-91
204. Zhao X, Loo SCJ, Lee PP-F, Tan TTY, Chu CK (2010) Synthesis and cytotoxic activities of chloropyridylimineplatinum( II) and chloropyridyliminecopper(II) surfacefunctionalized poly(amidoamine)dendrimers. J Inorg Biochem 104:105-110
205. 2 fragments. Nucl Med Biol 26: 943-950
206. 67/64Cu- labeled anti-L1-CAM antibody ch CE7: selection of copper ligands and PET imaging. Nucl Med Biol 30:417-427
207. 2-(pyridin-2-ylmethyl)-ethane-1,2- diamine and N-(2-(2-aminoethylamino) ethyl)picolinamide: an in vitro and in vivo study. J Inorg Biochem 101:148-158